title: The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.
authors.forename: Khaled M
authors.initials: KM
authors.lastname: Musallam
authors.forename: Thurayya
authors.initials: T
authors.lastname: Arayssi
authors.forename: Ali T
authors.initials: AT
authors.lastname: Taher
authors.forename: Nadim
authors.initials: N
authors.lastname: Kanj
authors.forename: Imad
authors.initials: I
authors.lastname: Uthman
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D001691:Biological Therapy; D005260:Female; D006784:Hospitals, Teaching; D006801:Humans; D000069285:Infliximab; D007861:Lebanon; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012216:Rheumatic Diseases / Q000628:therapy*; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab; D000069285:Infliximab